AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition – Meet them this November
Talawar Therapeutics Heads to Nasdaq via SPAC Deal to Bankroll Eczema Asset
10 Clinical Trials to Watch Out for in the latter half of 2026 – Read here
Akero execs reunite to advance long-acting psoriasis pill
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
Sanofi halts development of troubled immune drug in eczema
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
Regeneron backs $75M series A for antibody upstart Infinimmune
Companies Attending Our 10th Anniversary Include: AbbVie, Galderma, Merck, Eli Lilly, Sun Pharma, AOBiome, Navigator Medicines, and lots more - View the Event Guide
Explore the Agenda to Discover the Translational to Access Priorities Shaping Dermatology R&D in 2026
Explore a focused agenda of scientific case studies, expert panels and interactive discussions designed to help you discover novel targets, improve translational confidence, optimize clinical development, differentiate therapies and accelerate the next generation of dermatology innovation across both common and rare inflammatory skin diseases.
Partner to Position Your Solutions at the Centre of Active Dermatology Pipelines
Partner with the summit to showcase your capabilities to senior pharma and biotech teams actively seeking support across biomarkers, imaging, clinical trials, manufacturing and formulation.
Join Biopharma Experts to Connect with the Decision-Makers Driving Dermatology Development Forward
Join a global audience of 90+ senior leaders from pharma and biotech for high-value networking, candid peer exchange and relationship-building across preclinical and late-stage development, access and launch.